Neurogene, Inc. Common Stock

NGNE

Neurogene, Inc. is a biotechnology company that focuses on developing and commercializing therapies for rare genetic neurological disorders. The company leverages gene therapy and other innovative approaches to address unmet medical needs in neurodegenerative and genetic diseases.

$20.55 +0.49 (2.44%)
🚫 Neurogene, Inc. Common Stock does not pay dividends

Related Companies

NGL Energy Partners LP 9.00% Class B Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred Units representing limited partnership interests
NGLpB
NGL Energy Partners LP 9.625% Class C Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred Units representing limited partner interests
NGLpC
NATURAL GROCERS BY VITAMIN COTTAGE, INC
NATURAL GROCERS BY VITAMIN COTTAGE, INC
NGVC
Natural Gas Services Group, Inc.
Natural Gas Services Group, Inc.
NGS